Dr Andrew Clamp is a Consultant Medical Oncologist based at The Christie NHS Foundation Trust in Manchester.

Dr Clamp qualified in medicine by gaining a first class honours degree from the University of Cambridge and then subsequently completed his clinical training (BMBCh) at the University of Oxford in 1996. His specialist training in Medical Oncology has taken place in Manchester at the Christie Hospital.

During his training in Manchester he gained extensive experience in the design and running of clinical trials, particularly in ovarian cancer. He was awarded a PhD for work in the laboratory of Professor John Gallagher determining the role of heparan sulphate in determining the bioactivity of collagen- XVIII derived endostatin, a key endogenous anti-angiogenic protein. 

Dr Clamp is a Clinical Senior Lecturer and Women's Cancer Centre Lead for the Institute of Cancer Sciences, University of Manchester and has an Honorary Consultant Appointment in Medical Oncology at The Christie NHS Foundation Trust, Manchester. He sits on the National Cancer Research Institute Gynaecological Cancers Clinical Studies Group and both the ovarian and endometrial subgroups. Dr Clamp is also a Member of UCL Cancer Trials Unit Trials Steering Committee, and a member of the Scottish Gynaecological Cancers Clinical Trials Group.

Dr Clamp teaches regularly on the undergraduate medical course at the University of Manchester and as part of the MRes Oncology Programme. He has been invited to give several national/ international teaching lectures including 'Incorporating Anti-vascular therapy into the Management of Ovarian Cancer' at the European Cancer Congress in Amsterdam in October 2013.